Amicus Therapeutics Stock News

Thesis has closed a $7.7 million deal by selling its KEEP tokens to some of crypto’s top investors. Its TBTC project could get more bitcoin into DeFi.

Amicus Therapeutics (NASDAQ:FOLD) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a research note issued on Thursday, BidAskClub reports. A number of other r

Amicus Therapeutics (FOLD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Amicus Therapeutics (FOLD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Brokerages forecast that Amicus Therapeutics, Inc. (NASDAQ:FOLD) will report ($0.29) earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Five analysts have issued

S&P Biotech ETF (XBI) slumped -20% year-to-date, in-line with the S&P 500, due to the unrelenting coronavirus pandemic,. Heavy exposure to small caps contribute

Equities research analysts expect Amicus Therapeutics, Inc. (NASDAQ:FOLD) to announce $57.21 million in sales for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for A

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

Covid-19 headlines continue to dominate the headlines and the markets. It is likely to be continue to be rough sledding in the months ahead for investors. Howev

Mar 30, 2020 (The Expresswire) -- Global "Malonic Acid Market" compromises many advantages that have accelerated the adoption of absorption among various...

Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

Amicus Therapeutics, Inc. (NASDAQ:FOLD)’s stock price dropped 5.3% during trading on Friday . The stock traded as low as $8.73 and last traded at $8.94, approximately 4,287,716 shares changed hands

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index wa